Company Analysis

Heron Therapeutics, Inc. (HRTX)

Nasdaq: HRTX · Pharmaceutical Preparations · San Diego, CA · filing with the SEC since 1994
Grade4.3
◀ Past 5.2● Present 4.3▶ Future 3.7
1 est.

Who runs Heron Therapeutics, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Collard Craig A
Chief Executive Officer. First filing Mar 2023, latest Nov 3, 2026, 1 filing in all.
Officers reporting now
4
of 10 people with a filing in the last fifteen months
Directors reporting now
6
25 people on the record since 2007
Officerssales are open-market, Nov 10, 2025 to Nov 10, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Hensley Mark EarlChief Operating OfficerApr 2025Nov 10, 2026none
Collard Craig AChief Executive OfficerMar 2023Nov 3, 2026none
Duarte IraEVP, Chief Financial OfficerJun 2023Nov 3, 2026none
Forbes William PEVP, Chief Development OfficerJun 2023Nov 3, 2026none
Directorssales are open-market, Nov 10, 2025 to Nov 10, 2026
NameRoleFirst filingLatest filingSales, 12 months
Christian WaagedirectorJun 2016Feb 3, 2026none
Cusack ThomasdirectorNov 2025Feb 3, 2026none
Dissanaike SharmiladirectorSep 2021Feb 3, 2026none
Johnson Craig AdirectorJan 2014Feb 3, 2026none
Kaseta MichaeldirectorNov 2024Feb 3, 2026none
Morgan AdamdirectorFeb 2023Feb 3, 2026none
Owners of more than 10% of a classsales are open-market, Nov 10, 2025 to Nov 10, 2026
NameRoleFirst filingLatest filingSales, 12 months
Rosen David Efraim10% ownerFeb 2023Oct 17, 2025none
Rubric Capital Management LP10% ownerFeb 2023Oct 17, 2025none
Earlier names on the record20, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton HRTX · research, not advice